Ancestry matters: Building inclusivity into preclinical study design.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33989545.
- Also identified by DOI 10.1016/j.cell.2021.03.041.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human cell lines (CLs) are key assets for biomedicine but lack ancestral diversity. Here, we explore why genetic diversity among cell-based models is essential for making preclinical research more equitable and widely translatable. We lay out practical actions that can be taken to improve inclusivity in study design.
Medical subject headings
- Black or African American
- Biomedical Research
- Cell Line
- Precision Medicine
- White People